Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 12, 2022

SELL
$6.28 - $15.59 $125,600 - $311,800
-20,000 Reduced 28.57%
50,000 $399,000
Q1 2021

May 11, 2021

BUY
$33.06 - $56.93 $2.31 Million - $3.99 Million
70,000 New
70,000 $2.68 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Longitude (Cayman) Ltd. Portfolio

Follow Longitude (Cayman) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Longitude (Cayman) Ltd. with notifications on news.